T-Cell Repertoire in Tumor Radiation: The Emerging Frontier as a Radiotherapy Biomarker
Radiotherapy (RT) is a therapeutic modality that aims to eliminate malignant cells through the induction of DNA damage in the irradiated tumor site. In addition to its cytotoxic properties, RT also induces mechanisms that result in the promotion of antitumor immunity both locally within the irradiat...
Main Authors: | Constantin N. Baxevanis, Angelos D. Gritzapis, Ioannis F. Voutsas, Panagiota Batsaki, Maria Goulielmaki, Maria Adamaki, Vassilios Zoumpourlis, Sotirios P. Fortis |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-05-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/11/2674 |
Similar Items
-
Overview of methodologies for T-cell receptor repertoire analysis
by: Elisa Rosati, et al.
Published: (2017-07-01) -
Radiotherapy-Related Gene Signature in Prostate Cancer
by: Paraskevi Kogionou, et al.
Published: (2022-10-01) -
Evaluation and comparison of adaptive immunity through analyzing the diversities and clonalities of T-cell receptor repertoires in the peripheral blood
by: Yue Zhuo, et al.
Published: (2022-09-01) -
Promising Biomarkers in Head and Neck Cancer: The Most Clinically Important miRNAs
by: Arsinoe C. Thomaidou, et al.
Published: (2022-07-01) -
Human γδ TCR Repertoires in Health and Disease
by: Alina Suzann Fichtner, et al.
Published: (2020-03-01)